Laura Sutcliffe
Stock Analyst at UBS
(0.63)
# 3,994
Out of 4,979 analysts
7
Total ratings
42.86%
Success rate
-14.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $285 → $325 | $279.19 | +16.41% | 2 | Aug 1, 2025 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $21 → $22 | $9.29 | +136.81% | 2 | Jan 27, 2025 | |
| ARGX argenx SE | Initiates: Buy | $390 | $767.00 | -49.15% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $32.77 | - | 2 | Dec 20, 2019 |
ResMed
Aug 1, 2025
Maintains: Buy
Price Target: $285 → $325
Current: $279.19
Upside: +16.41%
Telix Pharmaceuticals
Jan 27, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $9.29
Upside: +136.81%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $767.00
Upside: -49.15%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $32.77
Upside: -